These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6421274)

  • 1. A histological study on microthrombi in autopsy cases of DIC.
    Kojima M; Shimamura K; Mori N; Oka K; Nakazawa M
    Bibl Haematol; 1983; (49):95-106. PubMed ID: 6421274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal of fibrin thrombi in disseminated intravascular coagulation (DIC). Morphological studies.
    Shimamura K; Kozima M
    Arch Pathol Lab Med; 1981 Dec; 105(12):659-63. PubMed ID: 6895455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution patterns of microthrombi in disseminated intravascular coagulation.
    Shimamura K; Oka K; Nakazawa M; Kojima M
    Arch Pathol Lab Med; 1983 Oct; 107(10):543-7. PubMed ID: 6688518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated intravascular coagulation in autopsy cases. Its incidence and clinicopathologic significance.
    Watanabe T; Imamura T; Nakagaki K; Tanaka K
    Pathol Res Pract; 1979 Nov; 165(3):311-22. PubMed ID: 530889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
    [No Abstract]   [Full Text] [Related]  

  • 7. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J
    Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of gabexate mesilate against experimental disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Takemura S; Kondo M
    Haemostasis; 1983; 13(4):262-7. PubMed ID: 6413308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombosis in various diseases: disseminated intravascular coagulation and thrombosis].
    Terada H
    Nihon Rinsho; 1986 May; 44(5):1170-7. PubMed ID: 3091885
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
    Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
    Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological spectrum of renal pathology and its correlation to clinical features in patients with disseminated intravascular coagulation: a study involving a series of 21 autopsy cases.
    Ohashi R; Ishii H; Naito Z; Shimizu A
    Pathol Int; 2014 Sep; 64(9):443-52. PubMed ID: 25146453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histopathological picture of acute disseminated intravascular coagulation].
    Nozicka Z; Vortel V
    Cesk Patol; 1975 May; 11(2):90-5. PubMed ID: 53107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
    Aramoto H; Saito H; Shigematsu H; Muto T
    Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
    Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study on the liver in autopsy cases with disseminated intravascular coagulation (DIC) with reference to clinicopathological analysis.
    Esaki Y; Hirokawa K; Fukazawa T; Matsuda T
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(3):229-41. PubMed ID: 6208676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathology of disseminated intravascular coagulation].
    Sueishi K; Takeuchi M
    Nihon Rinsho; 1993 Jan; 51(1):30-6. PubMed ID: 8433525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti DIC therapy].
    Yahata M; Sakamoto Y
    Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
    Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
    J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.